Détail du document
Identifiant

oai:HAL:inserm-02360074v1

Sujet
French national health system data... cancer death factors palliative care timing [SDV.SPEE]Life Sciences [q-bio]/Sa...
Auteur
Janah, Asmaa Gauthier, Lynn, R Morin, Lucas Bousquet, Philippe Jean Le Bihan, Christine Tuppin, Philippe Peretti-Watel, Patrick Bendiane, Marc-Karim
Langue
en
Editeur

HAL CCSD;Dove Medical Press

Catégorie

sciences : sciences du vivant

Année

2019

Date de référencement

15/12/2023

Mots clés
study national died death 2013 palliative care patients access ci aor 95%
Métrique

Résumé

International audience; Background and purpose: Introducing palliative care earlier in the disease trajectory has been found to provide better management of physical and psychological suffering.

In France, the proportion of cancer patients who receive palliative care is unclear.

This study aimed primarily to measure the prevalence of access to inpatient palliative care and associated patient-level factors, and to identify the time between access to palliative care and death.

Patients and methods: A nationwide retrospective cohort study using data from the French national health system database (SNDS).

All those diagnosed with cancer in 2013 who died between 2013 and 2015 were included.

Access to inpatient palliative care was the main outcome.

Results: Of the 313,059 patients diagnosed with cancer in 2013 in France, 72,315 (23%) died between 2013 and 2015.

Overall, 57% had access to inpatient palliative care.

The following groups were the most likely to have access to palliative care: women (adjusted odds ratio, aOR: 1.15; 95% CI: 1.11-1.20), people aged 18-49 (aOR: 1.38; 95% CI: 1.26-1.51), individuals with metastatic cancer (aOR: 2.04; 95% CI: 1.96-2.13), and patients with cancer of the nervous system (aOR: 1.80; 95% CI: 1.62-2.01).

The median time between palliative care and death was 29 (interquartile range: 13-67) days.

Conclusion: More than half of cancer patients who died within 2 years after diagnosis had access to inpatient palliative care.

Access to palliative care occurs late in the disease trajectory, often during the final month of life.

Further research and guidelines are warranted to optimize access to early, standardized palliative care.

Janah, Asmaa,Gauthier, Lynn, R,Morin, Lucas,Bousquet, Philippe Jean,Le Bihan, Christine,Tuppin, Philippe,Peretti-Watel, Patrick,Bendiane, Marc-Karim, 2019, Access to palliative care for cancer patients between diagnosis and death: a national cohort study, HAL CCSD;Dove Medical Press

Document

Ouvrir

Partager

Source

Articles recommandés par ES/IODE IA

MELAS: Phenotype Classification into Classic-versus-Atypical Presentations
presentations mitochondrial strokelike patients variability phenotype clinical melas
Protocol for the promoting resilience in stress management (PRISM) intervention: a multi-site randomized controlled trial for adolescents and young adults with advanced cancer
cancer quality of life anxiety depression hope coping skills communication intervention randomized ayas outcomes resilience care trial cancer prism-ac advanced